Research & Literature

Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype.

van Meegeren ME, Mancini TL, Schoormans SC, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2015; (21(5)):e375-83 doi:10.1111/hae.12733.

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey.

Windyga J, Dolan G, Altisent C, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2016; (22(1)):110-20 doi:10.1111/hae.12763.

Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.

Song J, Chen F, Campos M, et al.

PloS one 2015; (10(8)):e0132626 doi:10.1371/journal.pone.0132626.

Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding.

Sanders YV, Fijnvandraat K, Boender J, et al.

American journal of hematology 2015; (90(12)):1142-8 doi:10.1002/ajh.24195.

Surgery in patients with von Willebrand disease.

Zulfikar B, Koc B, Ak G, et al.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2016; (27(7)):812-816 doi:10.1097/MBC.0000000000000500.

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Flood VH, Christopherson PA, Gill JC, et al.

Blood 2016; (127(20)):2481-8 doi:10.1182/blood-2015-10-673681.

Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.

Albánez S, Ogiwara K, Michels A, et al.

Journal of thrombosis and haemostasis : JTH 2016; (14(5)):953-63 doi:10.1111/jth.13294.

Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.

Tindall E

The Journal of the American Osteopathic Association 1999; (99(11_suppl)):S13-S17 doi:10.7556/jaoa.1999.99.11.S13.

Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.

Mason JA, Robertson JD, McCosker J, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2016; (22(5)):700-5 doi:10.1111/hae.12949.

How much do we really know about von Willebrand disease?

Swystun LL, Lillicrap D

Current opinion in hematology 2016; (23(5)):471-8 doi:10.1097/MOH.0000000000000272.

Monitoring Therapy during Treatment of von Willebrand Disease.

Favaloro EJ, Pasalic L, Curnow J

Seminars in thrombosis and hemostasis 2017; (43(3)):338-354 doi:10.1055/s-0036-1585080.

Tranexamic Acid in Anesthetic Management of Surgical Procedures.

Mayeux J, Alwon K, Collins S, Hewer I

AANA journal 2016; (84(3)):201-9.

Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.

Miesbach W, Berntorp E

European journal of haematology 2017; (98(2)):121-127 doi:10.1111/ejh.12809.

Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease.

Favaloro EJ

American journal of hematology 2017; (92(1)):114-118 doi:10.1002/ajh.24556.

Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.

Reynen E, James P

Seminars in thrombosis and hemostasis 2016; (42(7)):717-723 doi:10.1055/s-0036-1587686.

New treatment approaches to von Willebrand disease.

Lavin M, O'Donnell JS

Hematology. American Society of Hematology. Education Program 2016; (2016(1)):683-689 doi:10.1182/asheducation-2016.1.683.

Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.

Heilmann C, Trummer G, Beyersdorf F, et al.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2017; (51(3)):587-590 doi:10.1093/ejcts/ezw348.

Laboratory monitoring of replacement therapy for major surgery in von Willebrand disease.

Mannucci PM, Franchini M

Haemophilia : the official journal of the World Federation of Hemophilia 2017; (23(2)):182-187 doi:10.1111/hae.13165.

Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report.

Brown R

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2017; (28(7)):570-575 doi:10.1097/MBC.0000000000000632.

Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection.

Khan TW, Yacoub A

Case reports in anesthesiology 2017; (2017()):6467090 doi:10.1155/2017/6467090.

Perioperative bleeding and thrombotic risks in patients with Von Willebrand disease.

Smilowitz NR, Gupta N, Guo Y, et al.

Journal of thrombosis and thrombolysis 2017; (44(1)):67-70 doi:10.1007/s11239-017-1504-2.

Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.

Swystun LL, Georgescu I, Mewburn J, et al.

Journal of thrombosis and haemostasis : JTH 2017; (15(8)):1607-1619 doi:10.1111/jth.13749.

Dental management of patients with inherited bleeding disorders: a multidisciplinary approach.

Abed H, Ainousa A

General dentistry 2017; (65(6)):56-60.

Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors.

Alharbi A, Hassan SB, Al-Momen AK, et al.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(2)):211-215 doi:10.1097/MBC.0000000000000709.

Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.

Holm E, Carlsson KS, Lövdahl S, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2018; (24(4)):628-633 doi:10.1111/hae.13473.

Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding.

Jacobson AE, Vesely SK, Koch T, et al.

Obstetrics and gynecology 2018; (131(6)):1121-1129 doi:10.1097/AOG.0000000000002620.

Bleeding score in type 1 von Willebrand disease patients using the condensed MCMDM-1 vWD validated questionnaire.

Pathare A, Al Hajri F, Al Omrani S, et al.

International journal of laboratory hematology 2018; (40(5)):515-520 doi:10.1111/ijlh.12850.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

Pérez-Rodríguez A, Batlle J, Corrales I, et al.

PloS one 2018; (13(6)):e0197876 doi:10.1371/journal.pone.0197876.

Significant gynecological bleeding in women with low von Willebrand factor levels.

Lavin M, Aguila S, Dalton N, et al.

Blood advances 2018; (2(14)):1784-1791 doi:10.1182/bloodadvances.2018017418.

Von Willebrand disease in the elderly: clinical perspectives.

Chapin J

Clinical interventions in aging 2018; (13()):1531-1541 doi:10.2147/CIA.S136931.

[Diagnosis and management of von Willebrand disease].

Higasa S, Tokugawa T, Sawada A

[Rinsho ketsueki] The Japanese journal of clinical hematology 2018; (59(10)):2222-2232 doi:10.11406/rinketsu.59.2222.

Rare forms of von Willebrand disease.

Favaloro EJ

Annals of translational medicine 2018; (6(17)):345 doi:10.21037/atm.2018.09.10.

Type 2M Von Willebrand Disease: A Case Report.

Ghosh S, Bendi VS, Krishnamurthy J, et al.

Cureus 2018; (10(8)):e3112 doi:10.7759/cureus.3112.

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.

Deconinck S, Tersteeg C, Bailleul E, et al.

Research and practice in thrombosis and haemostasis 2018; (2(4)):762-766 doi:10.1002/rth2.12150.

Sports participation and physical activity in patients with von Willebrand disease.

Atiq F, Mauser-Bunschoten EP, Eikenboom J, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2019; (25(1)):101-108 doi:10.1111/hae.13629.

Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.

Topf HG, Strasser ER, Breuer G, et al.

BMC anesthesiology 2019; (19(1)):10 doi:10.1186/s12871-018-0672-8.

Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease.

Guddati AK, Rosovsky RP, Van Cott EM, Kuter DJ

International journal of laboratory hematology 2019; (41(3)):325-330 doi:10.1111/ijlh.12978.

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.

van Galen KP, Engelen ET, Mauser-Bunschoten EP, et al.

The Cochrane database of systematic reviews 2019; (4()):CD011385 doi:10.1002/14651858.CD011385.pub3.

[Diagnosing von Willebrand disease].

Vojdeman FJ, Philips M, Funding E, Gøtze JP

Ugeskrift for laeger 2019; (181(16)).

The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.

Delbrück C, Miesbach W

Acta haematologica 2019; (142(2)):71-78 doi:10.1159/000496820.

Pregnancy and delivery in women with von Willebrand disease.

Castaman G, James PD

European journal of haematology 2019; (103(2)):73-79 doi:10.1111/ejh.13250.

A Novel Case of Compound Heterozygous Type 3 Von Willebrand Disease.

Mandava M, Bergmann S, Lazarchick J

Annals of clinical and laboratory science 2019; (49(3)):393-394.

How we make an accurate diagnosis of von Willebrand disease.

Baronciani L, Peyvandi F

Thrombosis research 2020; (196()):579-589 doi:10.1016/j.thromres.2019.07.010.

Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center.

Moonla C, Akkawat B, Kittikalayawong Y, et al.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2019; (25()):1076029619866916 doi:10.1177/1076029619866916.

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.

Shao Y, Wu W, Xu G, et al.

Blood 2019; (134(20)):1745-1754 doi:10.1182/blood.2018886069.

Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents.

Borzutzky C, Jaffray J

JAMA pediatrics 2020; (174(2)):186-194 doi:10.1001/jamapediatrics.2019.5040.

Clinical Practice Guideline: Nosebleed (Epistaxis).

Tunkel DE, Anne S, Payne SC, et al.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2020; (162(1_suppl)):S1-S38 doi:10.1177/0194599819890327.

Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.

Tunkel DE, Anne S, Payne SC, et al.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2020; (162(1)):8-25 doi:10.1177/0194599819889955.

Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.

Szeto CC, Sugano K, Wang JG, et al.

Gut 2020; (69(4)):617-629 doi:10.1136/gutjnl-2019-319300.

Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience.

Rassoulzadegan M, Ala F, Jazebi M, et al.

International journal of hematology 2020; (111(4)):535-543 doi:10.1007/s12185-019-02814-8.

Congenital platelet disorders and health status-related quality of life.

Blaauwgeers MW, Kruip MJHA, Beckers EAM, et al.

Research and practice in thrombosis and haemostasis 2020; (4(1)):100-105 doi:10.1002/rth2.12281.

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.

Borràs N, Garcia-Martínez I, Batlle J, et al.

Thrombosis and haemostasis 2020; (120(3)):437-448 doi:10.1055/s-0040-1702227.

Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.

Kiouptsi K, Reinhardt C

Sub-cellular biochemistry 2020; (94()):437-464 doi:10.1007/978-3-030-41769-7_18.

Use of Desmopressin in Hyponatremia: Foe and Friend.

Achinger SG, Ayus JC

Kidney medicine 2019; (1(2)):65-70 doi:10.1016/j.xkme.2019.02.002.

Effective hemostasis in children with Von Willebrand factor defects undergoing adenotonsillar procedures.

Diaz R, Musso M, Mahoney D

Pediatric hematology and oncology 2021; (38(1)):25-35 doi:10.1080/08880018.2020.1806970.

Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?

Seidi Zadeh O, Ahmadinejad M, Amoohossein B, Homayoun S

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2020; (31(6)):382-386 doi:10.1097/MBC.0000000000000932.

How I treat von Willebrand disease.

Castaman G

Thrombosis research 2020; (196()):618-625 doi:10.1016/j.thromres.2020.07.051.

Translating the success of prophylaxis in haemophilia to von Willebrand disease.

Miesbach W, Berntorp E

Thrombosis research 2021; (199()):67-74 doi:10.1016/j.thromres.2020.12.030.

Endothelial Function in Patients With Von Willebrand Disease.

Noone S, Schubert R, Fichtlscherer S, et al.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2021; (27()):1076029620984546 doi:10.1177/1076029620984546.

Von Willebrand disease type 2N: An update.

Seidizadeh O, Peyvandi F, Mannucci PM

Journal of thrombosis and haemostasis : JTH 2021; (19(4)):909-916 doi:10.1111/jth.15247.

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

Connell NT, Flood VH, Brignardello-Petersen R, et al.

Blood advances 2021; (5(1)):301-325 doi:10.1182/bloodadvances.2020003264.

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

James PD, Connell NT, Ameer B, et al.

Blood advances 2021; (5(1)):280-300 doi:10.1182/bloodadvances.2020003265.

Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations.

Colonne CK, Reardon B, Curnow J, Favaloro EJ

Journal of blood medicine 2021; (12()):755-768 doi:10.2147/JBM.S266791.

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.

Kalot MA, Husainat N, El Alayli A, et al.

Blood advances 2022; (6(1)):62-71 doi:10.1182/bloodadvances.2021005430.

Examining international practices in the management of pregnant women with von Willebrand disease.

Lavin M, Sánchez Luceros A, Kouides P, et al.

Journal of thrombosis and haemostasis : JTH 2022; (20(1)):82-91 doi:10.1111/jth.15561.

Postpartum Hemorrhage in Patients with Type 1 von Willebrand Disease: A Systematic Review.

Pierce-Williams RAM, Makhamreh MM, Blakey-Cheung S, et al.

Seminars in thrombosis and hemostasis 2022; (48(2)):219-228 doi:10.1055/s-0041-1736572.

Patient-reported outcomes in autosomal inherited bleeding disorders: A systematic literature review.

van Hoorn ES, Houwing ME, Al Arashi W, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(2)):197-214 doi:10.1111/hae.14492.

[Non-steroidal anti-inflammatory drugs : clarification for the practitioner].

Bourdon F, Buchard PA, Rodrigues B, Gobin N

Revue medicale suisse 2022; (18(768)):235-240 doi:10.53738/REVMED.2022.18.768.235.

Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review.

El Alayli A, Brignardello Petersen R, Husainat NM, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(3)):373-387 doi:10.1111/hae.14550.

Tranexamic acid: Beyond antifibrinolysis.

Prudovsky I, Kacer D, Zucco VV, et al.

Transfusion 2022; (62 Suppl 1()):S301-S312 doi:10.1111/trf.16976.

Outcomes and management of pregnancy in women with bleeding disorder of unknown cause.

Castle D, Desborough MJR, Kemp M, et al.

Journal of thrombosis and haemostasis : JTH 2022; (20(11)):2519-2525 doi:10.1111/jth.15871.

Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives.

Favaloro EJ, Pasalic L

Seminars in thrombosis and hemostasis 2022; (48(6)):750-766 doi:10.1055/s-0042-1754331.

Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program.

Salazar E, Long TA, Smock KJ, et al.

Seminars in thrombosis and hemostasis 2022; (48(6)):690-699 doi:10.1055/s-0042-1749591.

Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews.

Castaman G, Katsarou O, Jansen N, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2023; (29(2)):411-422 doi:10.1111/hae.14655.

Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.

Dubinski I, Bechtold-Dalla Pozza S, Schmidt H

Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(12)):1544-1546 doi:10.1515/jpem-2022-0422.

What have we learned about the patient's experience of von Willebrand disease? A focus on women.

VanderMeulen H, Arya S, Nersesian S, et al.

Hematology. American Society of Hematology. Education Program 2022; (2022(1)):631-636 doi:10.1182/hematology.2022000391.

Diagnostic pitfalls and conundrums in type 1 von Willebrand disease.

Sidonio RF, Lavin M

Hematology. American Society of Hematology. Education Program 2022; (2022(1)):618-623 doi:10.1182/hematology.2022000389.

1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs.

Bosch-Sanz O, Rabadà Y, Biarnés X, et al.

International journal of molecular sciences 2022; (23(23)) doi:10.3390/ijms232314942.

Assessing Bleeding Symptoms in Pediatric Patients With Generalized Joint Hypermobility.

Kendel NE, Stanek JR, Thomas BB, et al.

Arthritis care & research 2023; (75(8)):1788-1794 doi:10.1002/acr.25074.

Management of heavy menstrual bleeding in women with bleeding disorders in a tertiary care center.

Kuthiala S, Grabell J, Relke N, et al.

Research and practice in thrombosis and haemostasis 2023; (7(3)):100119 doi:10.1016/j.rpth.2023.100119.

Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.

Favaloro EJ, Mohammed S, Vong R, Pasalic L

Methods in molecular biology (Clifton, N.J.) 2023; (2663()):679-691 doi:10.1007/978-1-0716-3175-1_45.

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3.

Bauer A, Friberg-Hietala S, Smania G, Wolfsegger M

Journal of blood medicine 2023; (14()):399-411 doi:10.2147/JBM.S395845.

Initial von Willebrand factor antigen values in adolescent females predict future values.

Cohen CT, Zobeck M, Powers JM

Haemophilia : the official journal of the World Federation of Hemophilia 2023; (29(6)):1547-1555 doi:10.1111/hae.14865.

Targeting von Willebrand disease: the current status and future directions of management therapies.

Franchini M, Focosi D

Expert review of hematology 2023; (16(11)):871-878 doi:10.1080/17474086.2023.2268282.

Opioid-Free Anesthesia for Awake Neurosurgery in a Patient With Asthma and Von Willebrand Disease: A Case Report.

Medeiros H, Nascimento MS, Da Silva Ferreira LP, et al.

Cureus 2023; (15(10)):e47103 doi:10.7759/cureus.47103.

von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease.

Sidonio RF, Boban A, Dubey L, et al.

Blood advances 2024; (8(6)):1405-1414 doi:10.1182/bloodadvances.2023011742.

von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis.

Okubo N, Sugawara S, Fujiwara T, et al.

Research and practice in thrombosis and haemostasis 2024; (8(1)):102284 doi:10.1016/j.rpth.2023.102284.

A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease.

Rugeri L, Thomas W, Schirner K, et al.

Thrombosis and haemostasis 2024; (124(9)):828-841 doi:10.1055/a-2253-9701.

Von Willebrand Disease and Pregnancy: Management Protocol From Labor to the Postpartum Period.

Muñoz Vargas BA, Contreras Valero SJ, Aragon Mendoza RL, et al.

Cureus 2024; (16(2)):e53465 doi:10.7759/cureus.53465.

Procedural outcomes in children with mild type 1 von Willebrand disease.

Heery S, Zimowski K, Mason SF, et al.

Research and practice in thrombosis and haemostasis 2024; (8(1)):102334 doi:10.1016/j.rpth.2024.102334.

Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH.

Baker RI, Choi P, Curry N, et al.

Journal of thrombosis and haemostasis : JTH 2024; (22(7)):2059-2070 doi:10.1016/j.jtha.2024.03.005.

Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.

Oliveira JA, Eskandar K, Chagas J, et al.

Contraception 2024; (135()):110450 doi:10.1016/j.contraception.2024.110450.

Gynecological bleeding in women with congenital bleeding disorders: A comprehensive cohort from Iran.

Zafarani A, Ghodratnia E, Amirzargar MR, et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2024; (63(4)):103941 doi:10.1016/j.transci.2024.103941.

Retrospective chart review of GI bleeding in people with von Willebrand disease.

Roberts JC, Escobar MA, Acharya S, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2024; (30(4)):970-980 doi:10.1111/hae.15034.

Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study.

Krahforst A, Yadegari H, Pavlova A, et al.

Journal of thrombosis and haemostasis : JTH 2024; (22(11)):3010-3034 doi:10.1016/j.jtha.2024.06.026.

von Willebrand disease.

Seidizadeh O, Eikenboom JCJ, Denis CV, et al.

Nature reviews. Disease primers 2024; (10(1)):51 doi:10.1038/s41572-024-00536-8.

Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study.

Hallam M, Pruett A, Biega C, et al.

Journal of pediatric hematology/oncology nursing 2024; (41(4)):292-297 doi:10.1177/27527530241246260.

Low von Willebrand factor-unraveling an enigma wrapped in a conundrum.

O'Donnell JS, Baker RI, Atiq F

Journal of thrombosis and haemostasis : JTH 2024; (22(12)):3383-3388 doi:10.1016/j.jtha.2024.08.015.

Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A.

He H, Huang K, Cheng X, et al.

Thrombosis research 2023; (232()):6-14 doi:10.1016/j.thromres.2023.10.009.

Review of Inherited Coagulation Disorders.

Hoang T, Dowdy RAE

Anesthesia progress 2024; (71(2)):87-95 doi:10.2344/anpr-71-2_continuing_edu.

Prophylaxis in von Willebrand disease with von Willebrand factor concentrate and nonfactor therapies.

van Kwawegen CB, Leebeek FWG

Research and practice in thrombosis and haemostasis 2024; (8(8)):102599 doi:10.1016/j.rpth.2024.102599.

von Willebrand disease and heavy menstrual bleeding: when and how to test.

Perez Botero J

Hematology. American Society of Hematology. Education Program 2024; (2024(1)):376-381 doi:10.1182/hematology.2024000563.

Invasive Intracranial Electroencephalography Monitoring in the Child with a Bleeding Disorder: Challenges and Considerations.

Wong G, Gurevich S, Teti S, et al.

Pediatric neurosurgery 2025; (60(1-2)):38-44 doi:10.1159/000543194.

The Diagnostic Assessment of Inherited Platelet Function Defects - Part 1: An Overview of the Diagnostic Approach and Laboratory Methods.

Hoepner G, Althaus K, Müller J, et al.

Hamostaseologie 2025; (45(3)):229-242 doi:10.1055/a-2436-5318.

Role of Desmopressin in Bleeding Disorders: What Indian Physicians Need to Know?

Malve H, Goswami P, Asalkar A, More D

The Journal of the Association of Physicians of India 2025; (73(1)):58-60 doi:10.59556/japi.73.0796.

Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update.

Ettingshausen CE, Lassila R, Escolar G, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(2)):247-262 doi:10.1111/hae.15138.

Translation and Cultural Adaptation of the ISTH-Bleeding Assessment Tool to European Portuguese.

Carneiro-Leão D, Teixeira S, Queirós Pereira R, et al.

Acta medica portuguesa 2025; (38(2)):75-78 doi:10.20344/amp.22374.

Recombinant von Willebrand factor use in obstetric anesthesia.

Sharpe EE, Pompeian RJ, Marshall AL

Proceedings (Baylor University. Medical Center) 2025; (38(2)):142-147 doi:10.1080/08998280.2024.2430141.

A 4-Week-Old Female Infant with Type 3 von Willebrand Disease Presenting with Nosebleeds and Uncontrolled Bleeding Following Surgical Frenectomy: A Clinical Case.

Zima A, Iwaniec T, Zdziarska J, et al.

The American journal of case reports 2025; (26()):e946625 doi:10.12659/AJCR.946625.

Transient Acquired von Willebrand Disease With a Type 2B Phenotype: Recognizing the Diagnostic Challenges.

Aslam S, Nguyen L, Rabichow L, et al.

Cureus 2025; (17(5)):e83470 doi:10.7759/cureus.83470.

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease.

Kiss C, Boda Z, Khayat CD, et al.

AJOG global reports 2025; (5(2)):100501 doi:10.1016/j.xagr.2025.100501.

Heavy Menstrual Bleeding and Hormonal Therapy in Women with Type 1 von Willebrand Disease Enrolled on the Zimmerman Program.

Machin N, Navarrete A, Rothenberger S, et al.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2025; (31()):10760296251359294 doi:10.1177/10760296251359294.

Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease-a cohort study.

Myrin-Westesson L, Elfvinge P, Zetterberg E, Olsson A

Research and practice in thrombosis and haemostasis 2025; (9(4)):102949 doi:10.1016/j.rpth.2025.102949.

Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study.

Willems SPE, Cnossen MH, van Es N, et al.

Research and practice in thrombosis and haemostasis 2025; (9(5)):102961 doi:10.1016/j.rpth.2025.102961.

[Diagnosis and treatment of von Willebrand disease].

Nagae C

[Rinsho ketsueki] The Japanese journal of clinical hematology 2025; (66(9)):1146-1157 doi:10.11406/rinketsu.66.1146.

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.

Díaz-Ajenjo L, Marín-Quílez A, Lama-Villanueva A, et al.

Journal of thrombosis and haemostasis : JTH 2026; (24(1)):146-154 doi:10.1016/j.jtha.2025.09.036.

Health-Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL-QoL Study.

von Mackensen S, Moorthi C, Fischer R, et al.

Haemophilia : the official journal of the World Federation of Hemophilia 2025; doi:10.1111/hae.70073.

(Un) Diagnosing von Willebrand disease.

Brenner MK, Christopherson PA, Flood VH

Hematology. American Society of Hematology. Education Program 2025; (2025(1)):127-130 doi:10.1182/hematology.2025000697.

The Interplay of Von Willebrand Disease and Women's Reproductive Health.

Langer AL, O'Brien SH

Blood advances 2025; doi:10.1182/bloodadvances.2025016486.

Von Willebrand Disease Type 2A: An Update.

Seidizadeh O, Baronciani L, Mannucci PM, Peyvandi F

Seminars in thrombosis and hemostasis 2026; doi:10.1055/a-2778-9989.

Von Willebrand disease: classification and epidemiology.

Castaman G, Bramante Federici A

Haematologica 2026; (111(1)):26-34 doi:10.3324/haematol.2024.286058.

Clinical and laboratory diagnosis of von Willebrand disease.

Tosetto A, Eikenboom J

Haematologica 2026; (111(1)):35-43 doi:10.3324/haematol.2024.286011.